Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
news.jastorm.com news.jastorm.com news.jastorm.com

Independent Media Studio

news.jastorm.com news.jastorm.com news.jastorm.com

Independent Media Studio

  • News
  • Books
  • Video Broadcast
  • Radio Broadcast
  • About
  • Contact
  • Funding
  • News
  • Books
  • Video Broadcast
  • Radio Broadcast
  • About
  • Contact
  • Funding
Close

Search

Subscribe
New FDA‑Approved Pill Cuts Stroke Recurrence by 26% — AI-generated editorial illustration
Health

New FDA‑Approved Pill Cuts Stroke Recurrence by 26%

By Kevin Clifford
November 14, 2026 2 Min Read
0

New FDA‑Approved Pill Cuts Stroke Recurrence by 26%

Sunharbo (asundexian) is the first factor XIa inhibitor approved by the FDA for secondary stroke prevention. Clinical trials show it can lower the risk of a repeat stroke by 26%, offering hope for patients who have already suffered a cerebrovascular event. However, the medication is not without limitations and potential side‑effects, and doctors will need to weigh the benefits against the risks for each patient.

What Sunharbo Does

Unlike traditional anticoagulants that target clotting factor Xa or thrombin, Sunharbo specifically inhibits factor XIa, a protein involved in the blood‑clotting cascade. By blocking this step, the drug reduces the likelihood that a new clot will form in the brain’s blood vessels, thereby lowering the chance of another stroke.

Clinical Evidence

In a large, randomized study involving thousands of stroke survivors, those who took Sunharbo daily experienced a 26% reduction in repeat stroke events compared with placebo. The trial also reported a lower incidence of major bleeding, a common concern with many anticoagulants.

Key Limitations and Risks

While the data are promising, Sunharbo is not a panacea. The drug’s safety profile still requires careful monitoring, especially in patients with kidney impairment or those on multiple blood‑thinning medications. Side‑effects such as bruising, mild gastrointestinal discomfort, and rare cases of liver enzyme elevation have been noted. Physicians must evaluate each patient’s overall risk of bleeding versus the benefit of stroke prevention.

How It Fits Into Stroke Care

Sunharbo adds a new tool to the arsenal of secondary stroke prevention. It may be particularly useful for patients who cannot tolerate traditional anticoagulants or who have a high risk of bleeding. As with any new therapy, ongoing post‑marketing surveillance will be essential to confirm long‑term safety and effectiveness.

For more details, read the full Fox News report: https://www.foxnews.com/health/stroke-survivors-get-fda-approved-daily-pill-shown-cut-repeat-risk.

Watch and listen free on JASTORM – Follow radio and video broadcasts free in the JASTORM app with your free account.

Author

Kevin Clifford

Kevin Clifford is an investigative journalist from Two Dot, Montana, known for his remarkably accurate coverage of international conflicts, humanitarian crises, and unexplained events. Unknown to the public, Kevin is virtually invincible and possesses the ability to generate and manipulate powerful magnetic fields. These abilities allow him to stop weapons, move metal objects, disrupt machinery, and protect others from danger—but they also interfere with cameras and electronic equipment. As a result, every photograph or video taken near him contains strange distortions, static, discoloration, or missing details, making clear evidence of his actions impossible to obtain. To the world, Kevin is simply a determined reporter with unusually defective footage; to his closest friends, he is a hidden guardian who uses journalism to uncover threats and magnetism to stop them.

Follow Me
Other Articles
The nWo’s Clear Mission: Why Modern Factions Falter — AI-generated editorial illustration
Previous

The nWo’s Clear Mission: Why Modern Factions Falter

Joran van der Sloot Caught in FBI Sting, Attempts to Extort $250K from Natalee Holloway’s Mother — AI-generated editorial illustration
Next

Joran van der Sloot Caught in FBI Sting, Attempts to Extort $250K from Natalee Holloway’s Mother

Archives

Categories

Copyright 2026 — news.jastorm.com. All rights reserved. Blogsy WordPress Theme